We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.75B
AUM Growth
+$182M
Cap. Flow
+$1.02M
Cap. Flow %
0.06%
Top 10 Hldgs %
16.22%
Holding
890
New
91
Increased
326
Reduced
388
Closed
74

Sector Composition

Rank Sector Weight
1 Healthcare 12.42%
2 Financials 10.3%
3 Technology 8.72%
4 Industrials 4.92%
5 Consumer Discretionary 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFR
801
Eaton Vance Senior Floating-Rate Fund
EFR
$319M
$132K 0.01%
+10,444
New +$127K
IRWD icon
802
Ironwood Pharmaceuticals
IRWD
$684M
$129K 0.01%
11,274
-242
-2% -$2.39K
ARBK
803
Argo Blockchain
ARBK
$41.1M
$128K 0.01%
158
-5
-3% -$1.61K
PLTK icon
804
Playtika
PLTK
$1.03B
$128K 0.01%
14,645
+3,291
+29% +$28.6K
RKLB icon
805
Rocket Lab Corp
RKLB
$49.2B
$121K 0.01%
+21,919
New +$99K
SBSW icon
806
Sibanye-Stillwater
SBSW
$7.51B
$120K 0.01%
22,120
-373
-2% -$1.93K
SLCA
807
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$115K 0.01%
10,207
-219
-2% -$2.6K
GGN
808
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$833M
$115K 0.01%
30,598
-306
-1% -$1.13K
ADCT icon
809
ADC Therapeutics
ADCT
$145M
$109K 0.01%
65,936
+8,069
+14% +$7.45K
BTAI icon
810
BioXcel Therapeutics
BTAI
$29.7M
$108K 0.01%
2,281
+160
+8% +$8.89K
OPRT icon
811
Oportun Financial
OPRT
$350M
$83.7K ﹤0.01%
21,400
-654
-3% -$2.79K
ACHR icon
812
Archer Aviation
ACHR
$5.23B
$67.7K ﹤0.01%
+11,019
New +$62.6K
NVAX icon
813
Novavax
NVAX
$1.29B
$63.3K ﹤0.01%
13,195
+1,615
+14% +$9.89K
AEG icon
814
Aegon
AEG
$13.9B
$59.1K ﹤0.01%
+10,253
New +$53.3K
ATRA icon
815
Atara Biotherapeutics
ATRA
$78.4M
$57K ﹤0.01%
4,445
-2,312
-34% -$53.9K
NGM
816
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$56.6K ﹤0.01%
65,936
+8,069
+14% +$7.08K
AAP icon
817
Advance Auto Parts
AAP
$3.35B
-6,823
Closed -$382K
ALGN icon
818
Align Technology
ALGN
$12.4B
-2,075
Closed -$634K
AVXL icon
819
Anavex Life Sciences
AVXL
$319M
-59,550
Closed -$390K
BGFV
820
DELISTED
Big 5 Sporting Goods
BGFV
-10,068
Closed -$70.6K
BLUE
821
DELISTED
bluebird bio
BLUE
-2,433
Closed -$148K
BUSE icon
822
First Busey Corp
BUSE
$2.57B
-11,704
Closed -$225K
BYSI icon
823
BeyondSpring
BYSI
$32.5M
-80,993
Closed -$64.8K
CAC icon
824
Camden National
CAC
$973M
-11,931
Closed -$337K
CF icon
825
CF Industries
CF
$18.1B
-2,568
Closed -$220K

Similar funds

Hennion & Walsh Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Hennion & Walsh Asset Management held 890 positions worth $1.75B, up 12% from $1.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management's Q4 2023 filing shows 91 new, 326 increased, 388 reduced and 74 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $6.66M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2023 buy was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M.
  • Hennion & Walsh Asset Management added most to iShares National Muni Bond ETF in Q4 2023, an estimated $3.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.66M.
  • Hennion & Walsh Asset Management fully exited Immunovant in Q4 2023, selling an estimated $5.49M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $1.75B portfolio in Q4 2023.
  • Hennion & Walsh Asset Management opened 91 new positions and closed 74 in Q4 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 12% quarter-over-quarter to $1.75B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.